Evidence map›Paper›PMID 31567046›Full record

ArticleHuman vaccines & immunotherapeutics2020

EB virus-positive tumors are inhibited by rBCG expressing hGM-CSF and LMP2A.

Yingchun Yan, Qing-Jie Xue, Ang Liu, Hui Wang, Honghua Zhang, Shuang Wang, Longyu Zhao, Yunqing Li, Xiuzhen Li, Yuanyuan Yang and 2 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Yingchun YanSchool of Mental Health, Jining Medical University, Shandong, China.
Qing-Jie XueSchool of Basic Medical, Jining Medical University, Shandong, China.
Ang LiuSchool of Basic Medical, Jining Medical University, Shandong, China.
Hui WangSchool of Basic Medical, Jining Medical University, Shandong, China.
Honghua ZhangSchool of Basic Medical, Jining Medical University, Shandong, China.
Shuang WangSchool of Basic Medical, Jining Medical University, Shandong, China.
Longyu ZhaoSchool of Basic Medical, Jining Medical University, Shandong, China.ORCID 0000-0002-5946-3304
Yunqing LiSchool of Basic Medical, Jining Medical University, Shandong, China.
Xiuzhen LiSchool of Basic Medical, Jining Medical University, Shandong, China.
Yuanyuan YangSchool of Basic Medical, Jining Medical University, Shandong, China.
Ting ChenSchool of Basic Medical, Jining Medical University, Shandong, China.
Shigen LiSchool of Basic Medical, Jining Medical University, Shandong, China.
Jining Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For the development of safe and effective EBV (Epstein-Barr virus) vaccines, the Ag85A signal peptide from

Indexed as

Epstein-Barr Virus InfectionsNeoplasmsAnimalsGranulocyte-Macrophage Colony-Stimulating FactorHerpesvirus 4, HumanMiceRecombinant Fusion ProteinsGranulocyte-Macrophage Colony-Stimulating FactorRecombinant Fusion Proteinscytotoxic lymphocyteEpstein-Barr virushGM-CSFLMP2Amice

Identifiers

PMID31567046
PMCPMC7227694
OpenAlexW2978997133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.